𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Disposition kinetics of disopyramide in patients with renal insufficiency

✍ Scribed by Danny D. Shen; John L. Cunningham; Isami Shudo; Daniel L. Azarnoff


Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
443 KB
Volume
1
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

✦ Synopsis


The pharmacokinetics of an intravenous injection of disopyramide was studied in five normal subjects and six patients with varying degrees of renal impairment. The elimination rate constant (p) was related to the endogenous creatinine clearance (Cl,,).

However, a decrease in / 3 was not observed until the Cl,, was reduced below 40 ml min-'. Below 40 ml min-l a linear relationship existed between fi and CL,. Similarly, the plasma elimination half-life (t& showed a significant increase when the Cl,, was less than 30 ml min-l. Hence, dosage modification for disopyramide is necessary only when renal function is severely impaired. Overall, the apparent volume of distribution in patients with renal insufficiency was reduced to two-thirds of that in normal subjects. Therefore, in patients with Cl,, less than 40 ml min-l both the loading and maintenance dose of disopyramide should be reduced.


πŸ“œ SIMILAR VOLUMES


Peripheral arterial disease in diabetic
✍ Mauri LepΓ€ntalo; Leslie Fiengo; Fausto Biancari πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 1 views

## Summary Peripheral arterial disease is common among diabetic patients with renal insufficiency, and most of the diabetic patients with end‐stage renal disease (ESRD) have peripheral arterial disease. Ischaemia is probably overrepresented as an etiological factor for a diabetic foot ulcer in this

Enantioselective kinetic disposition of
✍ Maria Paula Da Costa Marques; Osvaldo Massaiti Takayanagui; Pierina Sueli Bonato πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

The enantioselectivity of the kinetic disposition of albendazole sulfoxide (ASOX) was investigated in 18 patients with neurocysticercosis treated with a multiple dose regimen of albendazole for 8 days (5 mg/kg every 8 h). Serial blood samples were collected on the eighth day of treatment during the

Cerebellar toxicity with medium-dose cyt
✍ Chim, C.S.; Kwong, Y.L. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 1 views

a patient with myelodysplastic syndrome and acute myeloid leukemia evolving from polycythemia Vera (PV) treated with hydroxyurea for 4 years. A 43-year-old man presented with facial erythrosis and intense itching in June 1991. Physical examination revealed splenomegaly. Complete blood count reveale